Table 1. GHb is a Better Predictor of 8-year Fatal CVD & CHD in Women but not Men w/o Diabetes.
Men | Women | |
---|---|---|
HR (95% Cl) | HR (95% Cl) | |
CVD mortality | ||
GHb | 1.10 (0.61-1.97) | 2.61 (1.40-4.88) |
FPG | 0.75 (0.39-1.46) | 1.30 (0.61-2.81) |
PCG | 0.83 (0.47-1.45) | 1.01 (0.51-2.00) |
CHD mortality | ||
GHb | 1.25 (0.56-2.78) | 2.59 (1.14-5.85) |
FPG | 0.98 (0.42-2.30) | 0.98 (0.34-2.80) |
PCG | 0.90 (0.41-1.96) | 0.87 (0.34-2.21) |
Adjusted for age, systolic blood pressure, body mass index, LDL, HDL, triglycerides, smoking, anti-hypertension medications, and estrogen therapy use in women GHb (glycosylated hemoglobin); FPG (fasting plasma glucose) PCG (post-challenge glucose); CVD (cardiovascular disease); CHD (coronary heart disease); HR (hazard ratio); CI (confidence interval)
Adapted from S Park et al., Diabetes Care, 1996;19:450-456.